Active Chemopreventive Agent Development Grants

PI Name Organization - Company Titlesort descending Project Number Fiscal Year
Kroll, Eugene University Of Montana A combination therapy for interventional treatment of triple-negative breast cancer 1R15CA242394-01 2019
Wu, Xiangwei University Of Tx Md Anderson Can Ctr Activating p53 for colorectal cancer prevention 5R01CA214954-03 2020
Sun, Luzhe University Of Texas Hlth Science Center Aging mammary stem cells and breast cancer prevention 5R01CA192564-05 2019
Chang, Eric C Baylor College Of Medicine A novel N-Ras pathway driving DCIS to basal-like breast cancer 5R21CA226567-02 2019
Cao, Lei Ohio State University Cancer prevention and treatment by activation of a brain-adipocyte axis 5R01CA166590-08 2020
Sempere, Lorenzo Michigan State University Chemical ablation of ductal tree for breast cancer prevention 5R21CA226579-02 2020
You, Ming Medical College Of Wisconsin Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer 5R01CA223804-03 2020
Shen, Qiang University Of Tx Md Anderson Can Ctr Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 5R01CA226001-02 2019
Kang, Ningling University Of Minnesota Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway 5R01CA187027-05 2019
You, Ming Medical College Of Wisconsin Chemoprevention of lung cancer by targeting lonidamine to mitochondria 5R01CA232433-02 2020
You, Ming Medical College Of Wisconsin Chemoprevention of lung cancer with mitochondria-targeted honokiol 5R01CA208648-04 2020
Bissonnette, Bruce Marc University Of Chicago CXCR4 as a target for colon cancer chemoprevention 5R01CA240710-02 2020
Sharp, Zelton Dave University Of Texas Hlth Science Center Delaying intestinal cancer 5R01CA193835-05 2020
Feng, Xu University Of Alabama At Birmingham Discovery of Novel Drug Targets for Breast Cancer 5R21CA222763-02 2019
Fan, Daping University Of South Carolina At Columbia Emodin as a chemopreventive agent for breast cancer 5R01CA218578-03 2020

Pages